{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T16:20:20Z","timestamp":1785601220831,"version":"3.56.0"},"reference-count":118,"publisher":"Japan Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1507\/endocrj.ej20-0692","type":"journal-article","created":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T22:06:21Z","timestamp":1616450781000},"page":"763-780","source":"Crossref","is-referenced-by-count":50,"title":["Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma (T1aN0M0) in adults"],"prefix":"10.1507","volume":"68","author":[{"given":"Kazuhiko","family":"Horiguchi","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusaku","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Breast and Endocrine Surgery, Tokyo Women\u2019s Medical University, Tokyo 162-8666, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Iwaku","sequence":"additional","affiliation":[{"name":"Sapporo Thyroid Clinic (Ito Hospital), Sapporo 060-0042, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Emoto","sequence":"additional","affiliation":[{"name":"Diabetes & Thyroid Clinic, Sakura Chuo Hospital, Sakura 285-0014, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Kasahara","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kuma Hospital, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Shimura","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fukushima Medical University, Fukushima 960-1295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisakazu","family":"Shindo","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yamashita Thyroid Hospital, Fukuoka 812-0034, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Endocrinology, Division of Internal Medicine, Fukushima Medical University Hospital, Fukushima 960-1295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Nagano","sequence":"additional","affiliation":[{"name":"Department of Molecular Diagnosis, Graduate school of Medicine, Chiba University, Chiba 260-8670, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Furuya","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Yamanashi 409-3998, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Makita","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Juntendo University Faculty of Medicine, Tokyo 113-8421, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Manaka","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norisato","family":"Mitsutake","sequence":"additional","affiliation":[{"name":"Department of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki 852-8523, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Miyakawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyakawa Hospital, Kawasaki 210-0802, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Yokoya","sequence":"additional","affiliation":[{"name":"Thyroid and Endocrine Center, Fukushima Medical University, Fukushima 960-1295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwao","family":"Sugitani","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Nippon Medical School Graduate School of Medicine, Tokyo 113-8603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","unstructured":"1 Japan Association of Breast and Thyroid Sonology (2012) Thyroid Ultrasound-A guidebook for diagnosis and management, 2nd Edition. 1\u2013163 (In Japanese)."},{"key":"2","doi-asserted-by":"publisher","unstructured":"2 Bibbins-Domingo K, Grossman DC, Curry SJ, Barry MJ, Davidson KW, et al. (2017) Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 317: 1882\u20131887.","DOI":"10.1001\/jama.2017.4011"},{"key":"3","unstructured":"3 Japan Thyroid Association (2013) Guidelines for Clinical Practice for the Management of Thyroid Nodules in Japan 2013. 1\u2013277 (In Japanese)."},{"key":"4","doi-asserted-by":"publisher","unstructured":"4 Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, et al. (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26: 1\u2013133.","DOI":"10.1089\/thy.2015.0020"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Takami H, Ito Y, Noguchi H, Yoshida A, Okamoto T (eds) (2013) Treatment of thyroid tumor. Japanese clinical guidelines. Springer Japan.","DOI":"10.1007\/978-4-431-54049-6"},{"key":"6","unstructured":"6 Kojimahara N, Nakayama T, Morizane T, Yamaguchi N, Yoshida M (2017) Minds Manual for Guideline Development 2017 (In Japanese)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Salamanca-Fern\u00e1ndez E, Rodriguez-Barranco M, Chang-Chan YL, Redondo-S\u00e1nchez D, Dom\u00ednguez-L\u00f3pez S, et al. (2018) Thyroid Cancer Epidemiology in South Spain: a population-based time trend study. Endocrine 62: 423\u2013431.","DOI":"10.1007\/s12020-018-1681-6"},{"key":"8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12885-018-4081-7","volume":"18","author":"L Du","year":"2018","unstructured":"8 Du L, Wang Y, Sun X, Li H, Geng X, et al. (2018) Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China. BMC Cancer 18: 291.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Shulin JH, Aizhen J, Kuo SM, Tan WB, Ngiam KY, et al. (2018) Rising incidence of thyroid cancer in Singapore not solely due to micropapillary subtype. Ann R Coll Surg Engl 100: 295\u2013300.","DOI":"10.1308\/rcsann.2018.0004"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Dal Maso L, Panato C, Franceschi S, Serraino D, Buzzoni C, et al. (2018) The impact of overdiagnosis on thyroid cancer epidemic in Italy, 1998\u20132012. Eur J Cancer 94: 6\u201315.","DOI":"10.1016\/j.ejca.2018.01.083"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Jegerlehner S, Bulliard JL, Aujesky D, Rodondi N, Germann S, et al. (2017) Overdiagnosis and overtreatment of thyroid cancer: a population-based temporal trend study. PLoS One 12: e0179387.","DOI":"10.1371\/journal.pone.0179387"},{"key":"12","unstructured":"12 Vu\u010demilo L, Znaor T, Kuli\u0161 T, \u0160ekerija M, Znaor A (2015) Thyroid cancer incidence and mortality trends in Croatia 1988\u20132010. Acta Clin Croat 54: 30\u201337."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Hoang JK, Choudhury KR, Eastwood JD, Esclamado RM, Lyman GH, et al. (2014) An exponential growth in incidence of thyroid cancer: trends and impact of CT imaging. AJNR Am J Neuroradiol 35: 778\u2013783.","DOI":"10.3174\/ajnr.A3743"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Kweon SS, Shin MH, Chung IJ, Kim YJ, Choi JS (2013) Thyroid cancer is the most common cancer in women, based on the data from population-based cancer registries, South Korea. Jpn J Clin Oncol 43: 1039\u20131046.","DOI":"10.1093\/jjco\/hyt102"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Morris LG, Sikora AG, Tosteson TD, Davies L (2013) The increasing incidence of thyroid cancer: the influence of access to care. Thyroid 23: 885\u2013891.","DOI":"10.1089\/thy.2013.0045"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Veiga LH, Neta G, Aschebrook-Kilfoy B, Ron E, Devesa SS (2013) Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997\u20132008. Thyroid 23: 748\u2013757.","DOI":"10.1089\/thy.2012.0532"},{"key":"17","unstructured":"17 Ram\u00edrez-Vick M, Nieves-Rodr\u00edguez M, L\u00fagaro-G\u00f3mez A, P\u00e9rez-Irizarry J (2011) Increasing incidence of thyroid cancer in Puerto Rico, 1985-2004. P R Health Sci J 30: 109\u2013115."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Zhu C, Zheng T, Kilfoy BA, Han X, Ma S, et al. (2009) A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973\u20132004. Thyroid 19: 1061\u20131066.","DOI":"10.1089\/thy.2008.0342"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19 Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973\u20132002. JAMA 295: 2164\u20132167.","DOI":"10.1001\/jama.295.18.2164"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Oh CM, Jung KW, Won YJ, Shin A, Kong HJ, et al. (2015) Age-Period-Cohort Analysis of Thyroid Cancer Incidence in Korea. Cancer Res Treat 47: 362\u2013369.","DOI":"10.4143\/crt.2014.110"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM (2017) Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974\u20132013. JAMA 317: 1338\u20131348.","DOI":"10.1001\/jama.2017.2719"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Mirian C, Gr\u00f8nh\u00f8j C, Jensen DH, Jakobsen KK, Karnov K, et al. (2018) Trends in thyroid cancer: retrospective analysis of incidence and survival in Denmark 1980\u20132014. Cancer Epidemiol 55: 81\u201387.","DOI":"10.1016\/j.canep.2018.05.009"},{"key":"23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12885-018-4083-5","volume":"18","author":"U Jayarajah","year":"2018","unstructured":"23 Jayarajah U, Fernando A, Prabashani S, Fernando EA, Seneviratne SA (2018) Incidence and histological patterns of thyroid cancer in Sri Lanka 2001\u20132010: an analysis of national cancer registry data. BMC Cancer 18: 163.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Liu FC, Lin HT, Lin SF, Kuo CF, Chung TT, et al. (2017) Nationwide cohort study on the epidemiology and survival outcomes of thyroid cancer. Oncotarget 8: 78429\u201378451.","DOI":"10.18632\/oncotarget.19488"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Rojo \u00c1lvaro J, Bermejo Fraile B, Men\u00e9ndez Torre E, Ardanaz E, Guevara M, et al. (2017) Increased incidence of thyroid cancer in Navarra (Spain). Evolution and clinical characteristics, 1986\u20132010. Endocrinol Diabetes Nutr 64: 303\u2013309.","DOI":"10.1016\/j.endien.2017.02.016"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Vaccarella S, Dal Maso L, Laversanne M, Bray F, Plummer M, et al. (2015) The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries. Thyroid 25: 1127\u20131136.","DOI":"10.1089\/thy.2015.0116"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Hakala T, Kellokumpu-Lehtinen P, Kholov\u00e1 I, Holli K, Huhtala H, et al. (2012) Rising incidence of small size papillary thyroid cancers with no change in disease-specific survival in Finnish thyroid cancer patients. Scand J Surg 101: 301\u2013306.","DOI":"10.1177\/145749691210100415"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Londero SC, Krogdahl A, Bastholt L, Overgaard J, Pedersen HB, et al. (2013) Papillary thyroid carcinoma in Denmark 1996\u20132008: an investigation of changes in incidence. Cancer Epidemiol 37: e1\u2013e6.","DOI":"10.1016\/j.canep.2012.10.011"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Olaleye O, Ekrikpo U, Moorthy R, Lyne O, Wiseberg J, et al. (2011) Increasing incidence of differentiated thyroid cancer in South East England: 1987\u20132006. Eur Arch Otorhinolaryngol 268: 899\u2013906.","DOI":"10.1007\/s00405-010-1416-7"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Morris LG, Myssiorek D (2010) Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg 200: 454\u2013461.","DOI":"10.1016\/j.amjsurg.2009.11.008"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Rego-Iraeta A, P\u00e9rez-M\u00e9ndez LF, Mantinan B, Garcia-Mayor RV (2009) Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma. Thyroid 19: 333\u2013340.","DOI":"10.1089\/thy.2008.0210"},{"key":"32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2407-6-102","volume":"6","author":"R Scheiden","year":"2006","unstructured":"32 Scheiden R, Keipes M, Bock C, Dippel W, Kieffer N, et al. (2006) Thyroid cancer in Luxembourg: a national population-based data report (1983\u20131999). BMC Cancer 6: 102.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Montanaro F, Pury P, Bordoni A, Lutz JM, Swiss Cancer Registries Network (2006) Unexpected additional increase in the incidence of thyroid cancer among a recent birth cohort in Switzerland. Eur J Cancer Prev 15: 178\u2013186.","DOI":"10.1097\/01.cej.0000197450.94980.36"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Gomez Segovia I, Gallowitsch HJ, Kresnik E, Kumnig G, Igerc I, et al. (2004) Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984\u20132001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on thyroid carcinoma incidence. Thyroid 14: 277\u2013286.","DOI":"10.1089\/105072504323030933"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Lundgren CI, Hall P, Ekbom A, Frisell J, Zedenius J, et al. (2003) Incidence and survival of Swedish patients with differentiated thyroid cancer. Int J Cancer 106: 569\u2013573.","DOI":"10.1002\/ijc.11275"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Konturek A, Barczy\u0144ski M, Stopa M, Nowak W (2016) Trends in prevalence of thyroid cancer over three decades: a retrospective cohort study of 17,526 surgical patients. World J Surg 40: 538\u2013544.","DOI":"10.1007\/s00268-015-3322-z"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Hughes DT, Haymart MR, Miller BS, Gauger PG, Doherty GM (2011) The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid 21: 231\u2013236.","DOI":"10.1089\/thy.2010.0137"},{"key":"38","unstructured":"38 Griniatsos J, Tsigris C, Kanakis M, Kaltsas G, Michail O, et al. (2009) Increased incidence of papillary thyroid cancer detection among thyroidectomies in Greece between 1991 and 2006. Anticancer Res 29: 5163\u20135169."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Grodski S, Brown T, Sidhu S, Gill A, Robinson B, et al. (2008) Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 144: 1038\u20131043; discussion 1043.","DOI":"10.1016\/j.surg.2008.08.023"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Farahati J, Geling M, M\u00e4der U, M\u00f6rtl M, Luster M, et al. (2004) Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981\u20131995. Thyroid 14: 141\u2013147.","DOI":"10.1089\/105072504322880382"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Merhy J, Driscoll HK, Leidy JW, Chertow BS (2001) Increasing incidence and characteristics of differentiated thyroid cancer in Huntington, West Virginia. Thyroid 11: 1063\u20131069.","DOI":"10.1089\/105072501753271761"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Malandrino P, Russo M, Ronchi A, Minoia C, Cataldo D, et al. (2016) Increased thyroid cancer incidence in a basaltic volcanic area is associated with non-anthropogenic pollution and biocontamination. Endocrine 53: 471\u2013479.","DOI":"10.1007\/s12020-015-0761-0"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 O\u2019Grady TJ, Gates MA, Boscoe FP (2015) Thyroid cancer incidence attributable to overdiagnosis in the United States 1981\u20132011. Int J Cancer 137: 2664\u20132673.","DOI":"10.1002\/ijc.29634"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Ahn HS, Kim HJ, Welch HG (2014) Korea\u2019s thyroid-cancer \u201cepidemic\u201d\u2014screening and overdiagnosis. N Engl J Med 371: 1765\u20131767.","DOI":"10.1056\/NEJMp1409841"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Pelizzo MR, Rubello D, Bernardi C, Gemo G, Bertazza L, et al. (2014) Thyroid surgical practices shaping thyroid cancer incidence in North-Eastern Italy. Biomed Pharmacother 68: 39\u201343.","DOI":"10.1016\/j.biopha.2013.10.001"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Furuya-Kanamori L, Bell KJL, Clark J, Glasziou P, Doi SAR (2016) Prevalence of differentiated thyroid cancer in autopsy studies over six decades: a meta-analysis. J Clin Oncol 34: 3672\u20133679.","DOI":"10.1200\/JCO.2016.67.7419"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Wiest PW, Hartshorne MF, Inskip PD, Crooks LA, Vela BS, et al. (1998) Thyroid palpation <i>versus<\/i> high-resolution thyroid ultrasonography in the detection of nodules. J Ultrasound Med 17: 487\u2013496.","DOI":"10.7863\/jum.1998.17.8.487"},{"key":"48","unstructured":"48 Takebe K, Ito M, Yamamoto Y, Hagino T, Takeuchi Y (1994) Mass screening for thyroid cancer with ultrasonography. KARKINOS 7: 309\u2013317 (In Japanese)."},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Zevallos JP, Hartman CM, Kramer JR, Sturgis EM, Chiao EY (2015) Increased thyroid cancer incidence corresponds to increased use of thyroid ultrasound and fine-needle aspiration: a study of the Veterans Affairs health care system. Cancer 121: 741\u2013746.","DOI":"10.1002\/cncr.29122"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Hoang JK, Nguyen XV, Davies L (2015) Overdiagnosis of thyroid cancer: answers to five key questions. Acad Radiol 22: 1024\u20131029.","DOI":"10.1016\/j.acra.2015.01.019"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Nayan S, Ramakrishna J, Gupta MK (2014) The proportion of malignancy in incidental thyroid lesions on 18-FDG PET study: a systematic review and meta-analysis. Otolaryngol Head Neck Surg 151: 190\u2013200.","DOI":"10.1177\/0194599814530861"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Shie P, Cardarelli R, Sprawls K, Fulda KG, Taur A (2009) Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography. Nucl Med Commun 30: 742\u2013748.","DOI":"10.1097\/MNM.0b013e32832ee09d"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 O\u2019Grady TJ, Kitahara CM, DiRienzo AG, Boscoe FP, Gates MA (2014) Randomization to screening for prostate, lung, colorectal and ovarian cancers and thyroid cancer incidence in two large cancer screening trials. PLoS One 9: e106880.","DOI":"10.1371\/journal.pone.0106880"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Yu XM, Wan Y, Sippel RS, Chen H (2011) Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Ann Surg 254: 653\u2013660.","DOI":"10.1097\/SLA.0b013e318230036d"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Ito Y, Fukushima M, Kihara M, Takamura Y, Kobayashi K, et al. (2012) Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size. Endocr J 59: 457\u2013464.","DOI":"10.1507\/endocrj.EJ12-0013"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Sugitani I, Fujimoto Y (1999) Symptomatic <i>versus<\/i> asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocr J 46: 209\u2013216.","DOI":"10.1507\/endocrj.46.209"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57 Noguchi S, Yamashita H, Uchino S, Watanabe S (2008) Papillary microcarcinoma. World J Surg 32: 747\u2013753.","DOI":"10.1007\/s00268-007-9453-0"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58 Kim E, Choi JY, Koo DH, Lee KE, Youn YK (2015) Differences in the characteristics of papillary thyroid microcarcinoma \u22645 mm and &gt;5 mm in diameter. Head Neck 37: 694\u2013697.","DOI":"10.1002\/hed.23654"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59 Buffet C, Golmard JL, Hoang C, Tr\u00e9sallet C, Du Pasquier F\u00e9diaevsky L, et al. (2012) Scoring system for predicting recurrences in patients with papillary thyroid microcarcinoma. Eur J Endocrinol 167: 267\u2013275.","DOI":"10.1530\/EJE-12-0105"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60 Cheema Y, Repplinger D, Elson D, Chen H (2006) Is tumor size the best predictor of outcome for papillary thyroid cancer? Ann Surg Oncol 13: 1524\u20131528.","DOI":"10.1245\/s10434-006-9176-8"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61 Mehanna H, Al-Maqbili T, Carter B, Martin E, Campain N, et al. (2014) Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up. J Clin Endocrinol Metab 99: 2834\u20132843.","DOI":"10.1210\/jc.2013-2118"},{"key":"62","unstructured":"62 Japan Association of Breast and Thyroid Sonology (2016) Thyroid Ultrasound-A guidebook for diagnosis and management, 3rd edition. 1\u2013200 (In Japanese)."},{"key":"63","unstructured":"63 Haddad R, Lydiatt W, Bischoff, L, Busaidy N, Byrd D, et al. (2019) National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Thyroid Carcinoma Version 2."},{"key":"64","doi-asserted-by":"crossref","unstructured":"64 Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, et al. (2017) ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol 14: 587\u2013595.","DOI":"10.1016\/j.jacr.2017.01.046"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65 Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, et al. (2019) Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 30: 1856\u20131883.","DOI":"10.1093\/annonc\/mdz400"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66 Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, et al. (2017) European Thyroid Association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS. Eur Thyroid J 6: 225\u2013237.","DOI":"10.1159\/000478927"},{"key":"67","doi-asserted-by":"publisher","unstructured":"67 Shimura H, Haraguchi K, Hiejima Y, Fukunari N, Fujimoto Y, et al. (2005) Distinct diagnostic criteria for ultrasonographic examination of papillary thyroid carcinoma: a multicenter study. Thyroid 15: 251\u2013258.","DOI":"10.1089\/thy.2005.15.251"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68 Brito JP, Gionfriddo MR, Al Nofal A, Boehmer KR, Leppin AL, et al. (2014) The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and meta-analysis. J Clin Endocrinol Metab 99: 1253\u20131263.","DOI":"10.1210\/jc.2013-2928"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69 Campanella P, Ianni F, Rota CA, Corsello SM, Pontecorvi A (2014) Quantification of cancer risk of each clinical and ultrasonographic suspicious feature of thyroid nodules: a systematic review and meta-analysis. Eur J Endocrinol 170: R203\u2013R211.","DOI":"10.1530\/EJE-13-0995"},{"key":"70","doi-asserted-by":"publisher","unstructured":"70 Remonti LR, Kramer CK, Leit\u00e3o CB, Pinto LC, Gross JL (2015) Thyroid ultrasound features and risk of carcinoma: a systematic review and meta-analysis of observational studies. Thyroid 25: 538\u2013550.","DOI":"10.1089\/thy.2014.0353"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71 Ito Y, Onoda N, Okamoto T (2020) The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: core questions and recommendations for treatments of thyroid cancer. Endocr J 67: 669\u2013717.","DOI":"10.1507\/endocrj.EJ20-0025"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72 Sugitani I, Toda K, Yamada K, Yamamoto N, Ikenaga M, et al. (2010) Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg 34: 1222\u20131231.","DOI":"10.1007\/s00268-009-0359-x"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73 Park SY, Kim HI, Kim JH, Kim JS, Oh YL, et al. (2018) Prognostic significance of gross extrathyroidal extension invading only strap muscles in differentiated thyroid carcinoma. Br J Surg 105: 1155\u20131162.","DOI":"10.1002\/bjs.10830"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74 Huang XP, Ye TT, Zhang L, Liu RF, Lai XJ, et al. (2018) Sonographic features of papillary thyroid microcarcinoma predicting high-volume central neck lymph node metastasis. Surg Oncol 27: 172\u2013176.","DOI":"10.1016\/j.suronc.2018.03.004"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75 Wang WH, Xu SY, Zhan WW (2016) Clinicopathologic factors and thyroid nodule sonographic features for predicting central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective study of 1204 patients. J Ultrasound Med 35: 2475\u20132481.","DOI":"10.7863\/ultra.15.10012"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76 Zhao C, Jiang W, Gao Y, Niu W, Zhang X, et al. (2017) Risk factors for lymph node metastasis (LNM) in patients with papillary thyroid microcarcinoma (PTMC): role of preoperative ultrasound. J Int Med Res 45: 1221\u20131230.","DOI":"10.1177\/0300060517708943"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77 Dom\u00ednguez JM, Nilo F, Mart\u00ednez MT, Massardo JM, Mu\u00f1oz S, et al. (2018) Papillary thyroid microcarcinoma: characteristics at presentation, and evaluation of clinical and histological features associated with a worse prognosis in a Latin American cohort. Arch Endocrinol Metab 62: 6\u201313.","DOI":"10.20945\/2359-3997000000013"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78 Lee YC, Jung AR, Sohn YM, Kim EJ, Eun YG (2018) Ultrasonographic features associated with false-negative and false-positive results of extrathyroidal extensions in papillary thyroid microcarcinoma. Eur Arch Otorhinolaryngol 275: 2817\u20132822.","DOI":"10.1007\/s00405-018-5115-0"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79 Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, et al. (2006) Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 30: 780\u2013786.","DOI":"10.1007\/s00268-005-0270-z"},{"key":"80","doi-asserted-by":"publisher","unstructured":"80 Kwak JY, Kim EK, Youk JH, Kim MJ, Son EJ, et al. (2008) Extrathyroid extension of well-differentiated papillary thyroid microcarcinoma on US. Thyroid 18: 609\u2013614.","DOI":"10.1089\/thy.2007.0345"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81 Jung SP, Kim M, Choe JH, Kim JS, Nam SJ, et al. (2013) Clinical implication of cancer adhesion in papillary thyroid carcinoma: clinicopathologic characteristics and prognosis analyzed with degree of extrathyroidal extension. World J Surg 37: 1606\u20131613.","DOI":"10.1007\/s00268-013-2034-5"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82 Xu Y, Xu L, Wang J (2018) Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution. J Surg Res 221: 128\u2013134.","DOI":"10.1016\/j.jss.2017.08.007"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83 Diker-Cohen T, Hirsch D, Shimon I, Bachar G, Akirov A, et al. (2018) Impact of minimal extra-thyroid extension in differentiated thyroid cancer: systematic review and meta-analysis. J Clin Endocrinol Metab 103: 2100\u20132106.","DOI":"10.1210\/jc.2018-00081"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84 Moon HJ, Kim EK, Chung WY, Yoon JH, Kwak JY (2011) Minimal extrathyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor? Ann Surg Oncol 18: 1916\u20131923.","DOI":"10.1245\/s10434-011-1556-z"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85 Ahn D, Sohn JH, Jeon JH, Jeong JY (2014) Clinical impact of microscopic extrathyroidal extension in patients with papillary thyroid microcarcinoma treated with hemithyroidectomy. J Endocrinol Invest 37: 167\u2013173.","DOI":"10.1007\/s40618-013-0025-x"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86 Woo CG, Sung CO, Choi YM, Kim WG, Kim TY, et al. (2015) Clinicopathological significance of minimal extrathyroid extension in solitary papillary thyroid carcinomas. Ann Surg Oncol 22 Suppl 3: S728\u2013S733.","DOI":"10.1245\/s10434-015-4659-0"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87 Roti E, degli Uberti EC, Bondanelli M, Braverman LE (2008) Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol 159: 659\u2013673.","DOI":"10.1530\/EJE-07-0896"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88 Jeon MJ, Kim WG, Choi YM, Kwon H, Lee YM, et al. (2016) Features predictive of distant metastasis in papillary thyroid microcarcinomas. Thyroid 26: 161\u2013168.","DOI":"10.1089\/thy.2015.0375"},{"key":"89","doi-asserted-by":"publisher","unstructured":"89 Kawano S, Miyauchi A, Ito Y (2020) Routine chest computed tomography at presentation does not identify distant metastasis in cT1aN0 papillary thyroid carcinoma. Thyroid 30: 1620\u20131624.","DOI":"10.1089\/thy.2020.0073"},{"key":"90","doi-asserted-by":"publisher","unstructured":"90 Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, et al. (2014) Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid 24: 27\u201334.","DOI":"10.1089\/thy.2013.0367"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91 Tuttle RM, Fagin JA, Minkowitz G, Wong RJ, Roman B, et al. (2017) Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance. JAMA Otolaryngol Head Neck Surg 143: 1015\u20131020.","DOI":"10.1001\/jamaoto.2017.1442"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92 Fukuoka O, Sugitani I, Ebina A, Toda K, Kawabata K, et al. (2016) Natural history of asymptomatic papillary thyroid microcarcinoma: time-dependent changes in calcification and vascularity during active surveillance. World J Surg 40: 529\u2013537.","DOI":"10.1007\/s00268-015-3349-1"},{"key":"93","doi-asserted-by":"publisher","unstructured":"93 Oda H, Miyauchi A, Ito Y, Yoshioka K, Nakayama A, et al. (2016) Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance <i>versus<\/i> immediate surgery. Thyroid 26: 150\u2013155.","DOI":"10.1089\/thy.2015.0313"},{"key":"94","doi-asserted-by":"publisher","unstructured":"94 Miyauchi A, Kudo T, Ito Y, Oda H, Sasai H, et al. (2018) Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillance. Surgery 163: 48\u201352.","DOI":"10.1016\/j.surg.2017.03.028"},{"key":"95","doi-asserted-by":"publisher","unstructured":"95 Miyauchi A, Kudo T, Ito Y, Oda H, Yamamoto M, et al. (2019) Natural history of papillary thyroid microcarcinoma: kinetic analyses on tumor volume during active surveillance and before presentation. Surgery 165: 25\u201330.","DOI":"10.1016\/j.surg.2018.07.045"},{"key":"96","doi-asserted-by":"publisher","unstructured":"96 Sakai T, Sugitani I, Ebina A, Fukuoka O, Toda K, et al. (2019) Active surveillance for T1bN0M0 papillary thyroid carcinoma. Thyroid 29: 59\u201363.","DOI":"10.1089\/thy.2018.0462"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97 Kwon H, Oh HS, Kim M, Park S, Jeon MJ, et al. (2017) Active surveillance for patients with papillary thyroid microcarcinoma: a single center\u2019s experience in Korea. J Clin Endocrinol Metab 102: 1917\u20131925.","DOI":"10.1210\/jc.2016-4026"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98 Kim HI, Jang HW, Ahn HS, Ahn S, Park SY, et al. (2018) High serum TSH level is associated with progression of papillary thyroid microcarcinoma during active surveillance. J Clin Endocrinol Metab 103: 446\u2013451.","DOI":"10.1210\/jc.2017-01775"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99 Oh HS, Ha J, Kim HI, Kim TH, Kim WG, et al. (2018) Active surveillance of low-risk papillary thyroid microcarcinoma: a multi-center cohort study in Korea. Thyroid 28: 1587\u20131594.","DOI":"10.1089\/thy.2018.0263"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100 Oh HS, Kwon H, Song E, Jeon MJ, Kim TY, et al. (2019) Tumor volume doubling time in active surveillance of papillary thyroid carcinoma. Thyroid 29: 642\u2013649.","DOI":"10.1089\/thy.2018.0609"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101 Molinaro E, Campopiano MC, Pieruzzi L, Matrone A, Agate L, et al. (2020) Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at a single italian center. J Clin Endocrinol Metab 105: e172\u2013e180.","DOI":"10.1210\/clinem\/dgz113"},{"key":"102","unstructured":"102 Ishihara M, Inaishi T, Miyajima N, Sibata M, Takano Y, et al. (2019) A study of non-operative follow-up cases for papillary thyroid cancer. Officail Journal of the Japan Association of Endocirne Surgions and the Japanese Society of Thyroid Surgery 36: 4 (In Japanese)."},{"key":"103","doi-asserted-by":"publisher","unstructured":"103 Sanabria A (2020) Experience with active surveillance of thyroid low-risk carcinoma in a developing country. Thyroid 30: 985\u2013991.","DOI":"10.1089\/thy.2019.0522"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104 Hirokawa M, Kudo T, Ota H, Suzuki A, Miyauchi A (2016) Pathological characteristics of low-risk papillary thyroid microcarcinoma with progression during active surveillance. Endocr J 63: 805\u2013810.","DOI":"10.1507\/endocrj.EJ16-0097"},{"key":"105","doi-asserted-by":"crossref","unstructured":"105 Koshkina A, Fazelzad R, Sugitani I, Miyauchi A, Thabane L, et al. (2020) Association of patient age with progression of low-risk papillary thyroid carcinoma under active surveillance: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg 146: 552\u2013560.","DOI":"10.1001\/jamaoto.2020.0368"},{"key":"106","doi-asserted-by":"crossref","unstructured":"106 Giordano D, Gradoni P, Oretti G, Molina E, Ferri T (2010) Treatment and prognostic factors of papillary thyroid microcarcinoma. Clin Otolaryngol 35: 118\u2013124.","DOI":"10.1111\/j.1749-4486.2010.02085.x"},{"key":"107","doi-asserted-by":"crossref","unstructured":"107 Kuo SF, Chao TC, Chang HY, Hsueh C, Yang CH, et al. (2011) Prognostic evaluation of patients with multicentric papillary thyroid microcarcinoma. J Formos Med Assoc 110: 511\u2013517.","DOI":"10.1016\/S0929-6646(11)60077-6"},{"key":"108","doi-asserted-by":"crossref","unstructured":"108 Lang BH, Wong CK (2015) A cost-effectiveness comparison between early surgery and non-surgical approach for incidental papillary thyroid microcarcinoma. Eur J Endocrinol 173: 367\u2013375.","DOI":"10.1530\/EJE-15-0454"},{"key":"109","doi-asserted-by":"publisher","unstructured":"109 Lin JF, Jonker PKC, Cunich M, Sidhu SB, Delbridge LW, et al. (2020) Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillance. Surgery 167: 110\u2013116.","DOI":"10.1016\/j.surg.2019.05.078"},{"key":"110","doi-asserted-by":"crossref","unstructured":"110 Venkatesh S, Pasternak JD, Beninato T, Drake FT, Kluijfhout WP, et al. (2017) Cost-effectiveness of active surveillance <i>versus<\/i> hemithyroidectomy for micropapillary thyroid cancer. Surgery 161: 116\u2013126.","DOI":"10.1016\/j.surg.2016.06.076"},{"key":"111","doi-asserted-by":"crossref","unstructured":"111 Oda H, Miyauchi A, Ito Y, Sasai H, Masuoka H, et al. (2017) Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid. Endocr J 64: 59\u201364.","DOI":"10.1507\/endocrj.EJ16-0381"},{"key":"112","doi-asserted-by":"crossref","unstructured":"112 Smulever A, Pitoia F (2019) Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America. Arch Endocrinol Metab 63: 462\u2013469.","DOI":"10.20945\/2359-3997000000168"},{"key":"113","doi-asserted-by":"crossref","unstructured":"113 Davies L, Roman BR, Fukushima M, Ito Y, Miyauchi A (2019) Patient experience of thyroid cancer active surveillance in Japan. JAMA Otolaryngol Head Neck Surg 145: 363\u2013370.","DOI":"10.1001\/jamaoto.2018.4131"},{"key":"114","doi-asserted-by":"crossref","unstructured":"114 Jeon MJ, Lee YM, Sung TY, Han M, Shin YW, et al. (2019) Quality of life in patients with papillary thyroid microcarcinoma managed by active surveillance or lobectomy: a cross-sectional study. Thyroid 29: 956\u2013962.","DOI":"10.1089\/thy.2018.0711"},{"key":"115","doi-asserted-by":"crossref","unstructured":"115 Yoshida Y, Horiuchi K, Okamoto T (2020) Patients\u2019 view on the management of papillary thyroid microcarcinoma: active surveillance or surgery. Thyroid 30: 681\u2013687.","DOI":"10.1089\/thy.2019.0420"},{"key":"116","doi-asserted-by":"publisher","unstructured":"116 Kong SH, Ryu J, Kim MJ, Cho SW, Song YS, et al. (2019) Longitudinal assessment of quality of life according to treatment options in low-risk papillary thyroid microcarcinoma patients: active surveillance or immediate surgery (interim analysis of MAeSTro). Thyroid 29: 1089\u20131096.","DOI":"10.1089\/thy.2018.0624"},{"key":"117","doi-asserted-by":"publisher","unstructured":"117 Sugitani I, Ito Y, Miyauchi A, Imai T, Suzuki S (2019) Active surveillance <i>versus<\/i> immediate surgery: questionnaire survey on the current treatment strategy for adult patients with low-risk papillary thyroid microcarcinoma in Japan. Thyroid 29: 1563\u20131571.","DOI":"10.1089\/thy.2019.0211"},{"key":"118","doi-asserted-by":"publisher","unstructured":"118 Sugitani I, Ito Y, Takeuchi D, Nakayama H, Masaki C, et al. (2021) Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery task force on management for papillary thyroid microcarcinoma. Thyroid 31: 183\u2013192.","DOI":"10.1089\/thy.2020.0330"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/7\/68_EJ20-0692\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T03:59:07Z","timestamp":1627703947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/7\/68_EJ20-0692\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":118,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej20-0692","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"EJ20-0692"}}